Apollo Endosurgery, Inc. (APEN)

NASDAQ: APEN · IEX Real-Time Price · USD
10.02
0.00 (0.00%)
At close: Dec 9, 2022 4:00 PM
10.06
+0.04 (0.40%)
After-hours: Dec 9, 2022 6:18 PM EST
Market Cap 417.42M
Revenue (ttm) 71.71M
Net Income (ttm) -40.69M
Shares Out 40.85M
EPS (ttm) -0.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,101,974
Open 10
Previous Close 10.02
Day's Range 10 - 10.03
52-Week Range 3.49 - 10.3
Beta 2.39
Analysts Buy
Price Target 12.04 (+20.2%)
Earnings Date Nov 1, 2022

About APEN

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under t... [Read more]

Industry Health Care Equipment & Supplies
Founded 2005
CEO Gary Atkinson
Employees 202
Stock Exchange NASDAQ
Ticker Symbol APEN
Full Company Profile

Financial Performance

In 2021, APEN's revenue was $62.99 million, an increase of 49.80% compared to the previous year's $42.05 million. Losses were -$24.68 million, 9.16% more than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for APEN stock is "Buy." The 12-month stock price forecast is 12.04, which is an increase of 20.16% from the latest price.

Price Target
$12.04
(20.16% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Apollo Endosurgery, Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - December 6, 2022) - Rigrodsky Law, P.A. is investigating Apollo Endosurgery, Inc. ("Apollo") (NASDAQ GM: APEN) regarding possible breaches of fiduciary duties and...

3 days ago - Newsfile Corp

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, GRAY, APEN, SAL

NEW YORK , Dec. 6, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of...

Other symbols: GRAYIMGOSAL
3 days ago - PRNewsWire

SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Apollo Endosurgery, Inc. - APEN

New York, New York--(Newsfile Corp. - December 5, 2022) -  Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national sec...

4 days ago - Newsfile Corp

APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Ad...

NEW ORLEANS--( BUSINESS WIRE )--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Apollo Endosurge...

Other symbols: BSX
1 week ago - Business Wire

SHAREHOLDER ALERT: Weiss Law Investigates Apollo Endosurgery, Inc.

NEW YORK , Nov. 29, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Apollo Endosurgery, Inc. ("Apollo Endosur...

Other symbols: BSX
1 week ago - PRNewsWire

Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham

Boston Scientific Corp.'s BSX, +0.88% $615 million acquisition of Apollo Endosurgery Inc. APEN, +65.50% announced earlier is complementary to the former's endoscopy franchise, as it leverages its gastro...

Other symbols: BSX
1 week ago - Market Watch

Apollo Endosurgery (APEN) Stock Soars 65% on Boston Scientific Deal

One of the medical technology sector's most dynamic players is maneuvering to gain a bigger market share. This morning, Boston Scientific (NYSE: BSX ) announced that it is acquiring Apollo Endosurgery (...

Other symbols: BSX
1 week ago - InvestorPlace

Shareholder Alert: Ademi LLP investigates whether Apollo Endosurgery, Inc. has obtained a Fair Price in its Transacti...

MILWAUKEE , Nov. 29, 2022 /PRNewswire/ -- Ademi LLP is investigating Apollo Endosurgery (Nasdaq: APEN) for possible breaches of fiduciary duty and other violations of law in its transaction with Boston ...

1 week ago - PRNewsWire

APEN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apollo Endosurgery, Inc. Is Fair to Shareholders

NEW YORK--( BUSINESS WIRE )--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Apollo Endosurgery, Inc. (NASDAQ: APEN) to Boston Scientific Corporation for $10.00 per s...

1 week ago - Business Wire

Boston Scientific to acquire Apollo Endosurgery for $615 million in cash

Boston Scientific Corp. BSX, -0.82% said Tuesday it has agreed to acquire Apollo Endosurgery Inc. APEN, for $10 a share, or about $615 million in cash. The news sent Apollo's stock, which closed Monday ...

Other symbols: BSX
1 week ago - Market Watch

Apollo Endosurgery to be Acquired by Boston Scientific

Boston Scientific to acquire Apollo for $10.00 per share in cash AUSTIN, TX / ACCESSWIRE / November 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leading minimally invasive medical dev...

Other symbols: BSX
1 week ago - Accesswire

Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.

Acquisition to expand endoluminal surgery portfolio and add differentiated technologies for endobariatric procedures MARLBOROUGH, Mass. , Nov. 29, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYS...

Other symbols: BSX
1 week ago - PRNewsWire

Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 i...

OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ACCES...

2 weeks ago - Accesswire

Apollo Endosurgery, Inc. (APEN) Reports Q3 Loss, Tops Revenue Estimates

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -33.33% and 8.95%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the st...

1 month ago - Zacks Investment Research

Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022

Grew global revenue 20% GAAP, 24% in constant currency Received FDA authorization for Apollo ESGTM and Apollo REVISETM systems for treating patients with obesity AUSTIN, TX / ACCESSWIRE / November 1, 20...

1 month ago - Accesswire

Apollo Endosurgery to Report Third Quarter Results on November 1, 2022

AUSTIN, TX / ACCESSWIRE / October 18, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal an...

1 month ago - Accesswire

Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami

Patients undergoing ESG achieved 24% total body weight loss in a bariatric surgery practice in a community setting. AUSTIN, TX / ACCESSWIRE / August 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDA...

3 months ago - Accesswire

Apollo Endosurgery, Inc. (APEN) Reports Q2 Loss, Tops Revenue Estimates

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -23.81% and 7.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022

Grew global revenue 16% (20% in constant currency) as adoption increased across all product lines Secured FDA marketing authorization for Apollo ESGTM and Apollo REVISETM AUSTIN, TX / ACCESSWIRE / Augus...

4 months ago - Accesswire

Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Proce...

Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™ AUSTIN, TX / ACCESSWIRE / July 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invas...

4 months ago - Accesswire

Apollo Endosurgery to Report Second Quarter Results on August 2, 2022

AUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and b...

4 months ago - Accesswire

Apollo Endosurgery's New Obesity Endoscopic Systems Receive FDA Nod

Apollo Endosurgery Inc (NASDAQ: APEN) announced the marketing authorization of the Apollo ESG, Apollo ESG Sx, Apollo REVISE, and Apollo REVISE Sx Systems through the FDA De Novo Classification process. ...

4 months ago - Benzinga

FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endosc...

Systems Offer Effective, Minimally Invasive Treatment Options for Millions of Patients with Obesity (BMI 30-50 kg/m2) AUSTIN, TX / ACCESSWIRE / July 13, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDA...

4 months ago - Accesswire

Sharon O'Keefe Joins Apollo Endosurgery Board of Directors

Seasoned healthcare leader brings 30 years of hospital system and medical technology expertise AUSTIN, TX / ACCESSWIRE / July 6, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader...

5 months ago - Accesswire

Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apol...

AUSTIN, TX / ACCESSWIRE / May 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced...

6 months ago - Accesswire